Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-069012
Filing Date
2025-07-18
Accepted
2025-07-18 16:02:01
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2521171-1_s3.htm S-3 240550
2 EXHIBIT 5.1 tm2521171d2_ex5-1.htm EX-5.1 8952
3 EXHIBIT 23.1 tm2521171d2_ex23-1.htm EX-23.1 2570
4 EX-FILING FEES tm2521171d2_ex-filingfees.htm EX-FILING FEES 21661
5 GRAPHIC tm2521171d2_ex5-1img001.jpg GRAPHIC 5852
6 GRAPHIC lg_nextcure-4c.jpg GRAPHIC 19226
  Complete submission text file 0001104659-25-069012.txt   309595
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288763 | Film No.: 251134456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)